Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02167607 · ClinicalTrials.gov registry record · NA

A Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in Humans

A NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT02167607: Completed NA study, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

NCT02167607 is a NA study that has completed, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02167607, a NA study, has completed, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Primary objective is to determine the bioavailability of and characterize the kinetic profile of target polyphenol metabolites of potatoes over 6 hour postprandial period. Secondary objective is to assess the influence of potatoes' bioavailability and kinetic profiles on markers of chronic diseases.

Primary Outcome

To assess the kinetic profile and bioavailability of potato polyphenols when consume with a meal

Interventions

  • DIETARY_SUPPLEMENT Placebo Comparator
  • DIETARY_SUPPLEMENT Active Comparator

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2014-06-01
Est. Completion 2014-11-11
Phase NA

What the finished NCT02167607 record still lists

NCT02167607 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo Comparator is the first listed.

NCT02167607 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02167607 about?

NCT02167607 is a clinical study titled "A Pilot Study to Characterize the Bioavailability and Plasma Profile of Potato Polyphenols in Humans". Primary objective is to determine the bioavailability of and characterize the kinetic profile of target polyphenol metabolites of potatoes over 6 hour postprandial period. Secondary objective is to assess the influence of potatoes' bioavailability and kinetic profiles on markers of chronic diseases...

What is the current status of trial NCT02167607?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2014-06-01. Estimated completion is 2014-11-11.

What interventions are being tested in trial NCT02167607?

The interventions under investigation include: Placebo Comparator (DIETARY_SUPPLEMENT), Active Comparator (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02167607?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02167607's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02167607, the US trial registry maintained by the National Library of Medicine. NCT02167607 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.